Richmond Pharmacology is pleased to join Swiss Biotech Day 2026 in Basel, Switzerland, on 4-5 May 2026.

Recognised as one of Europe’s leading biotechnology events, Swiss Biotech Day brings together industry pioneers, investors, research institutions, and global life science innovators to explore new partnerships, cutting‑edge technologies, and the future of biotech‑driven healthcare.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer
  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Emerging biotechnology platforms and novel therapeutic innovations
  • Early‑phase clinical development strategies
  • Regulatory, scientific, and partnering insights for global drug development
  • Collaboration opportunities across Europe’s expanding biotech landscape
  • Strengthening scientific, commercial, and translational partnerships

Connect With Us

If you are attending Swiss Biotech Day 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Home - Swiss Biotech Day

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event